Rheumatic features of sarcoidosis

Current Opinion in Rheumatology

Volumn 9, Issue 1, 1997, Pages 62-67

  Pettersson, Tom ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; FOLIC ACID ANTAGONIST; METHOTREXATE; T LYMPHOCYTE RECEPTOR;

ARTHRITIS; AUTOIMMUNITY; CLINICAL FEATURE; GRANULOMATOSIS; HELPER CELL; HUMAN; LUNG ALVEOLITIS; LUNG ALVEOLUS MACROPHAGE; MYOPATHY; PATHOGENESIS; POLYMYOSITIS; PRIORITY JOURNAL; REVIEW; SARCOIDOSIS; T LYMPHOCYTE;

EID: 0030966239     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-199701000-00012     Document Type: Review

References (42)

1. Chesnutt AN: Enigmas in sarcoidosis. West J Med 1995, 162:519-526. A comprehensive review on the natural history, clinical manifestations, assessment of disease activity, and therapeutic aspects of sarcoidosis.
2. DeRemee RA: Sarcoidosis. Mayo Clin Proc 1995, 70:177-181. A review focusing on several clinical aspects of sarcoidosis, including current concepts about how to diagnose stage, monitor, and treat the disease.
3. Milman N, Selroos O: Pulmonary sarcoidosis in the Nordic countries 1950-1982: epidemiology and clinical picture. Sarcoidosis 1990, 7:50-57.
4. Hunninghake GW, Crystal RG: Pulmonary sarcoidosis: a disease mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med 1981, 305:429-434.
5. Kita S, Tsuda T, Sugisaki K, Miyazaki E, Matsumoto T: Characterization of distribution of T lymphocyte subsets and activated T lymphocytes infiltrating into sarcoid lesions. Intern Med 1995, 34:847-855. A careful immunohistochemical characterization of T lymphocytes in the granulomatous lesions of sarcoidosis. T lymphocytes in the internal area of granulomas seem to be involved in granuloma formation and express activation markers, whereas T lymphocytes in the outer areas seem to suppress granuloma formation.
6. Swider C, Laba A, Moniewska A, Gerdes J, Flad HD, Lange A: Presence of mRNA for Interferon-gamma (IFN-γ) in blood mononuclear cells is associated with an active stage I sarcoidosis. Clin Exp Immunol 1995, 100:401-405. Expression of messenger RNA for interferon gamma in peripheral blood occurs mainly in active stage I sarcoidosis and especially in those with Löfgren's syndrome. Several clinical manifestations in Löfgren's syndrome may be explained by excessive production of interferon gamma.
7. + T cells in the inflammatory sites of patients with sarcoidosis are activated and produce more Th1 cell-type cytokines than Th2 cell-type cytokines.
8. James DG, Kay AB: Are you TH-1 or TH-2? Clin Exp Allergy 1995, 25:389-390.
9. Bjermer L, Eklund A, Blaschke E: Bronchoalveolar lavage fibronectin in patients with sarcoidosis: correlation to hyaluronan and disease activity. Eur Respir J 1991, 4:965-971.
10. 3 by activated macrophages and the development of hypercalcemia and hypercalciuria in sarcoidosis.
11. Melin M, Gjomarkaj M, Pace E, Malizia G, Spatafora M: Increased expression of leukocyte function associated antigen-1 (LFA-1) and intercellular adhesion molecule-1 (ICAM-1) by alveolar macrophages of patients with pulmonary sarcoidosis. Chest 1991, 100:910-916.
12. Ishii Y, Kitamura S: Elevated levels of soluble ICAM-1 in serum and BAL fluid in patients with active sarcoidosis. Chest 1995, 107:1636-1640. Soluble ICAM-1 in serum and bronchoalveolar lavage fluid is a new and promising marker for assessing and monitoring disease activity in sarcoidosis.
13. Striz I, Zneng L, Wang YM, Pokorná H, Bauer PC, Costabel U: Soluble CD14 is increased in bronchoalveolar lavage of active sarcoidosis and correlates with alveolar macrophage membrane-bound CD14. Am J Respir Crit Care Med 1995, 151:544-547. Bronchoalveolar lavage fluid from patients with active sarcoidosis contains high concentrations of a soluble form of CD 14, a myeloid differentiation antigen. The CD14 antigen may have a pathophysiologic role in sarcoidosis because it triggers the production of various cytokines.
14. Nagai S: Pulmonary sarcoidosis: pathogenesis and population differences. Intern Med 1995, 34:833-838. A comprehensive review of current concepts of the role of genetic and environmental factors in the development of sarcoidosis.
15. Tamura N, Moller DR, Balbi B, Crystal RG: Preferential use of the T-cell antigen receptor beta-chain constant region C beta 1 element by lung T-lymphocytes. Am Rev Respir Dis 1991, 143:635-639.
16. + T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients correlates with HLA-DR3. Eur J Immunol 1992, 22:129-135.
17. O'Brien, Happ MP, Dallas A: Stimulation of a major subset of lymphocytes expressing T-cell receptor gamma delta by an antigen derived from Mycobacterium tuberculosis. Cell 1989, 57:667-674.
18. Tazi A, Fajac I, Soler P, Valeyre D, Bettesti J, Hance A: Gamma/delta T-lymphocytes are not increased in number in granulomatous lesions of patients with tuberculosis or sarcoidosis. Am Rev Respir Dis 1991, 144:1373-1375.
19. Wilsher ML, Hallowes M, Birchall NM: Gamma/delta T lymphocytes in the blood of patients with sarcoidosis. Thorax 1995, 50:858-862. In agreement with previous studies suggesting that γ/δ T cells are unlikely to play a part in the pathogenesis of sarcoidosis, this study shows that T cells expressing the γ/δ TCR are not increased in the blood of patients with sarcoidosis.
20. Joyce-Brady M: "Tastes great less filling:" the debate about mycobacteria and sarcoidosis. Am Rev Respir Dis 1992, 145:986-987.
21. Saboor SA, Johnson NM, McFadden J: Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction. Lancet 1992, 339:1012-1015.
22. Bocart D, Lecossier D, De Lassence A, Valeyre D, Battesti J-P, Hance AJ: A search for mycobacterial DNA in granulomatous tissues from patients with sarcoidosis using the polymerase chain reaction. Am Rev Respir Dis 1992,145:1142-1148.
23. Kellner H, Spathling S, Herzer P: Ultrasound findings in Lofgren's syndrome: is arthritis caused by arthritis, tenosynovitis or periarthritis? J Rheumatol 1992, 19:38-41.
24. Glennȧs A, Kvien TK, Melby K, Refvem OK, Andrup O, Karstensen B, Thoen JE: Acute sarcoid arthritis: occurrence, seasonal onset, clinical features and outcome. Br J Rheumatol 1995, 34:45-50. A carefully conducted prospective clinical study showing that sarcoidosis is a common cause of acute oligoarthritis in young adults. The report confirms the clustering of acute sarcoid arthritis cases in the spring and the favorable outcome of the disease.
25. Kötter I, Dürk H, Saal JG: Sacroiliitis in sarcoidosis: case report and review of the literature. Clin Rheumatol 1995, 14:695-700.
26. Crowder SW, Jaffey LH: Sarcoidosis presenting as Achilles tendinitis. J R Soc Med 1995, 88:335-336.
27. Hearth-Holmes M, Campbell GD Jr: Muscle weakness, fatigue, and joint pain in a 52-year-old woman. Chest 1995, 108:563-564.
28. Ost D, Yeldandi A, Cugell D: Acute sarcoid myositis with respiratory muscle involvement: case report and review of the literature. Chest 1995, 107:879-882.
29. Matsuo M, Ehara S, Tamakawa Y, Chida E, Nishida J, Sugai T: Muscular sarcoidosis. Skeletal Radiol 1995, 34:535-537.
30. + T cells, the high CD4 to CD8 ratio, and the absence of HLA-ABC expression on muscle fibers were characteristic of granulomatous myositis.
31. Sweeney DC, Robertson JC: Osseous and central nervous system sarcoidosis: scintigraphic and radiographic findings. J Nucl Med 1995, 36:464-466.
32. Zickel RE, Bernstein RS, Ryan SF, Carney WP: Pathological ununited fractures of the long bones in a patient who had sarcoidosis. J Bone Joint Surg Am 1995, 77:440-443.
33. Enzenauer RJ, West SG: Sarcoidosis in autoimmune diseases. Semin Arthritis Rheum 1992, 22:1-17.
34. Takashita M, Torisu T, Shinmori Y: Mutilating rheumatoid arthritis associated with sarcoidosis: a case report Clin Rheumatol 1995, 14:576-579.
35. Collins DA, Bourke BE: Systemic lupus erythematosus: an occasional misdiagnosis. Ann Rheum Dis 1996, 55:421-422.
36. Cox D, Conant E, Earle L, Newman J, Kahaleh B, Jimenez S, Varga J: Sarcoidosis in systemic sclerosis: report of 7 cases. J Rheumatol 1995, 22:881-865. Sarcoidosis may coexist with scleroderma more often than has been thought. This coexistence may have therapeutic implications because patients with sarcoidosis may benefit from corticosteroid therapy.
37. Mizumoto M, Adachi Y, Chihara J, Matsumoto T, Yamamoto T, Nakajima S, Yamamoto T: A case of mixed connective tissue disease combined with sarcoidosis. Ann Rheum Dis 1994, 53:151.
38. Rouillon A, Menkes CJ, Gerster J-C, Perez-Sawka J, Forest M: Sarcoidlike forms of Whipple's disease: report of 2 cases. J Rheumatol 1993, 20:1070-1072.
39. Bricker H, Wilbek E: The Incidence of malignant tumours in patients with respiratory sarcoidosis. Br J Cancer 1974, 29:247-251.
40. Karakantza M, Matutes E, MacLennan K, O'Connor NTJ, Srivastava PC, Catovsky D: Association between sarcoidosis and lymphoma revisited. J Clin Pathol 1996, 49:208-212.
41. Reich JM, Mullooly JP, Johnson RE: Linkage analysis of malignancy-associated sarcoidosis. Chest 1995, 107:605-613.
42. Kaye O, Palazzo E, Grossin M, Bourgeois P, Kahn MF, Malaise MG: Low-dose methotrexate: an effective corticosteroid-sparing agent in the musculoskeletal manifestations of sarcoidosis. Br J Rheumatol 1995, 34:642-644. Methotrexate relieved symptoms and facilitated a reduction of the corticosteroid dose in patients with recalcitrant musculoskeletal manifestations of sarcoidosis.